Global Microbiome Sequencing Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 1,204.15 Million |
 Market Size (Forecast Year) |
USD 5,875.40 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球微生物组测序市场，按测序技术（高通量测序、桑格测序、SBL、RNA 测序、SBS、第三代测序、全基因组测序、靶向基因测序、散弹枪测序等）、组件（试剂和试剂盒、仪器）、目标疾病（中枢神经系统疾病、胃肠道疾病、肿瘤学、传染病等）、应用（个性化医疗、基因筛查、治疗、药物和生物标志物发现、疾病诊断研究等）、研究类型（外包、内部）、最终用户（制药和生物技术、学术中心和研究机构、CRO、其他）、实验室类型（干实验室、湿实验室）划分——行业趋势和预测到 2030 年。
微生物组测序市场分析和规模
基因组研究方法的采用率上升，加上微生物组测序技术应用领域的扩大，是推动全球微生物组测序市场增长的主要因素。此外，对下一代服务的需求不断增长，与 NGS 技术相关的低成本也将提高采用率，这些都是加速全球微生物组测序市场增长的驱动因素。在推进和利用微生物组研究方面增加的投资支出将促进市场的增长。
Data Bridge Market Research 分析称，全球微生物组测序市场规模在 2022 年为 12.0415 亿美元，预计到 2030 年将达到 58.754 亿美元，预计在 2023-2030 年预测期内的复合年增长率为 18.7%。高通量测序在全球微生物组测序市场的测序技术领域占据主导地位，因为此类分析仪的需求量很大。除了对市场价值、增长率、细分市场、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
微生物组测序市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
Sequencing Technology (High-Throughput Sequencing, Sanger Sequencing, SBL, RNA Sequencing, SBS, Third-Generation Sequencing, Whole Genome Sequencing, Targeted Gene Sequencing, Shotgun Sequencing, Others), Component (Reagents & Kits, Instruments), Targeted Disease (CNS Diseases, Gastrointestinal Diseases, Oncology, Infectious Diseases, Others), Application (Personalized Medicine, Genetic Screening, Therapeutic, Drug & Biomarker Discovery, Disease Diagnosis Research, Others), Research Type (Outsourced, In-House), End-User (Pharmaceutical & Biotechnology, Academic Centers & Research Institutes, CROs, Others), Laboratory Type (Dry Lab, Wet Lab) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
CosmosID (India), Charles River Laboratories(U.S.), Diversigen (U.S.), Illumina, Inc.(U.S.), Metabiomics Corp.(U.S.), Oxford Nanopore Technologies(U.K.), BaseClear B.V. (Netherlands), BGI (India), BioMathematica (U.S.), Microbiome Therapeutics Innovation Group (U.S.), Clinical-Microbiomics A/S (Denmark), Eurofins Scientific (Luxembourg), LABCYTE INC.(U.S.), Leucine Rich Bio Pvt Ltd.(India), Microbiome Insights(Canada), Zymo Research Corporation (U.S.), Thermo Fisher Scientific Inc.(U.S.), Molzym GmbH & Co. KG (Germany), Norgen Biotek Corp. (Canada), and Phase Genomics Inc. (U.S.) |
|
Market Opportunities |
|
Market Definition
Microbiome sequencing is defined as a research technology which includes the study of microbes and their roles in the maintenance of healthcare as well as prevalence of diseases. This is mainly carried out by sampling out the human blood, stool and skin. These samples are used for tests that are tried in the labour-intensive techniques of microbiology studies wherein they can isolate the organisms in these samples through the help of genotypic or phenotypic analysis.
Global Microbiome Sequencing Market Dynamics
Drivers
- Rising Prevalence of Chronic Diseases
The microbiome is increasingly linked to various chronic diseases, including obesity, diabetes, inflammatory bowel disease, and cancer. This connection has driven research into microbiome-based diagnostics, therapies, and interventions, further boosting the demand for microbiome sequencing.
- Personalized Medicine
The microbiome's role in personalized medicine is gaining traction. Understanding an individual's microbiome can help tailor treatments and therapies to their specific needs, potentially improving treatment outcomes and reducing side effects. This has led to increased interest in microbiome sequencing for personalized healthcare.
- Expanding Application Areas
Microbiome sequencing is not limited to human health. It is also widely used in agriculture, environmental science, and industrial applications. The expanding range of applications has broadened the market's scope and potential customer base.
Opportunities
- Strategic Collaborations and Partnerships
Many companies and research institutions are forming collaborations and partnerships to accelerate microbiome research and develop innovative products and services. These collaborations help drive innovation and expand market reach
-
Increasing Research Interest
Growing interest and awareness in the role of the human microbiome in health and disease have spurred extensive research efforts. Scientists and researchers are conducting microbiome studies to understand its impact on various aspects of human health, leading to increased demand for microbiome sequencing services and technologies.
Restraints/Challenges
- High Cost of Sequencing
Microbiome sequencing can be expensive, particularly when using advanced sequencing technologies. The cost of equipment, reagents, and data analysis can be a significant barrier for researchers and healthcare institutions, limiting their ability to conduct large-scale studies.
-
Data Analysis Challenges
The massive amount of data generated by microbiome sequencing requires sophisticated bioinformatics tools and expertise for analysis. Many researchers and clinicians may lack the necessary computational skills, leading to data analysis bottlenecks.
This global microbiome sequencing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global microbiome sequencing market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In June 2023, Zymo Research, announced that it has officially launched its Full-Length 16S Sequencing Service, offering researchers high-quality, full-length 16S rRNA gene sequencing for microbiome analysis
- In July 2022, OraSure Technologies launches new product for microbiome researchers to study DNA and RNA
Global Microbiome Sequencing Market Scope
The global microbiome sequencing market is segmented on the basis of sequencing technology, component, targeted disease, application, research type, end-user and laboratory type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Sequencing Technology
- High-Throughput Sequencing
- Sanger Sequencing
- SBL
- RNA Sequencing
- SBS
- Third-Generation Sequencing
- Whole Genome Sequencing
- Targeted Gene Sequencing
- Shotgun Sequencing
- Others
Component
- Reagents & Kits
- Instruments
Targeted Disease
- CNS Diseases
- Gastrointestinal Diseases
- Oncology
- Infectious Diseases
- Others
Application
- Personalized Medicine
- Genetic Screening
- Therapeutic
- Drug & Biomarker Discovery
- Disease Diagnosis Research
- Others
Research Type
- Outsourced
- In-House
End-User
- Pharmaceutical & Biotechnology
- Academic Centers & Research Institutes
- CROs
- Others
Laboratory Type
- Dry Lab
- Wet Lab
Global Microbiome Sequencing Market Analysis/Insights
The global microbiome sequencing market is analysed and market size insights and trends are provided by country, sequencing technology, component, targeted disease, application, research type, end-user and laboratory type as referenced above.
The countries covered in the global microbiome sequencing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the global microbiome sequencing market because of the strong base of healthcare facilities, strong presence of major players in the market, and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in healthcare facilities, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球微生物组测序市场份额分析
全球微生物组测序市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球微生物组测序市场的关注有关。
全球微生物组测序市场的一些主要参与者包括：
- CosmosID（印度）
- Charles River Laboratories（美国）
- Diversigen（美国）
- Illumina, Inc.（美国）
- Metabiomics Corp.（美国）
- 牛津纳米孔技术公司（英国）
- BaseClear BV（荷兰
- 华大基因（印度）
- BioMathematica（美国）
- 微生物组治疗创新小组（美国）
- Clinical-Microbiomics A/S（丹麦）
- Eurofins Scientific（卢森堡）
- LABCYTE INC.（美国）
- Leucine Rich Bio Pvt Ltd.（印度）
- Microbiome Insights（加拿大）
- Zymo 研究公司 (美国)
- 赛默飞世尔科技公司（美国）
- Molzym GmbH & Co. KG（德国）
- Norgen Biotek Corp.（加拿大）
- Phase Genomics Inc.（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
